Case Report Links Ramucirumab Plus Docetaxel to Rare Non-Perforating Colitis
A clinical case report identifies rare early-onset non-perforating inflammatory colitis following ramucirumab plus docetaxel therapy in a lung cancer patient.
A clinical case report identifies rare early-onset non-perforating inflammatory colitis following ramucirumab plus docetaxel therapy in a lung cancer patient.
A clinical case report found that third-line treatment with the bifunctional PD-1/CTLA-4 product QL1706 and chemotherapy achieved eight months of ...
A hospital-based real-world study in Northwest China found that docetaxel- and anthracycline-based chemotherapy regimens demonstrated comparable overall cardiovascular disease risks ...
A multicenter randomized noninferiority trial evaluates whether sequential intravenous and intra-arterial chemotherapy preserves eyes in children with unilateral retinoblastoma while ...
A real-world retrospective study found a linear dose–response relationship between carboplatin exposure and pathologic complete response in patients receiving neoadjuvant ...
A systematic review and meta-analysis of randomized controlled trials found that adding carboplatin to chemotherapy significantly improved pathological complete response ...
Clinicians report a rare case of delayed drug-induced interstitial lung disease developing over three months after neoadjuvant chemoimmunotherapy for lung ...
A six-year-old girl with an aggressive, disseminated diffuse leptomeningeal glioneuronal tumor achieved a complete radiological response following eight cycles of ...
A phase II trial in stage II to IIIB lung squamous cell carcinoma found that neoadjuvant camrelizumab combined with chemotherapy ...
Physicians in Pakistan diagnosed localized esophageal squamous cell carcinoma in a 16-year-old male following an acute episode of hematemesis.
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine